Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment

Brain Research

Volumn 799, Issue 2, 1998, Pages 215-229

  Reddy, Doodipala S ^a   Kulkarni, Shrinivas K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Aging; Dehydroepiandrosterone; Dizocilpine; Learning; Memory; Neurosteroid; Nitric oxide; NMDA receptor; Passive avoidance; Plus maze; Pregnenolone

Indexed keywords

DIZOCILPINE; N(G) NITROARGININE METHYL ESTER; NEUROSTEROID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PRASTERONE SULFATE; PREGNENOLONE SULFATE;

AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; HORMONE ACTION; LEARNING DISORDER; LONG TERM MEMORY; MAZE TEST; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AGING; AMNESIA; ANIMALS; AVOIDANCE LEARNING; DEHYDROEPIANDROSTERONE SULFATE; DIZOCILPINE MALEATE; ENZYME INHIBITORS; LEARNING DISORDERS; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED STRAINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOOTROPIC AGENTS; PREGNENOLONE;

EID: 0032551572     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00419-3     Document Type: Article

References (50)

1. G.A. Bohme, C. Bon, J.-M. Stutzmann, A. Doble, J.-C. Blanchard, Possible involvement of nitric oxide in long-term potentiation, Eur. J. Pharmacol. 199 (1991) 379-381.
2. G.A. Bohme, C. Bon, M. Lemaire, M. Reibaud, O. Piot, J.M. Stutzmann, A. Doble, J.C. Blanchard, Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats, Proc. Natl. Acad. Sci. USA 90 (1993) 9191-9194.
3. D.S. Bredt, S.H. Snyder, Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme, Proc. Natl. Acad. Sci. USA 87 (1990) 682-685.
4. D.S. Bredt, P.M. Hwang, S.H. Snyder, Localization of nitric oxide synthase indicating a neural role for nitric oxide, Nature 347 (1990) 768-770.
5. G. Brignola, A. Calignano, M.D. Rosa, Modulation of morphine antinociception in the mouse by endogenous nitric oxide, Br. J. Pharmacol. 113 (1994) 1372-1376.
6. E. Costa, J. Auta, A. Guidotti, A. Korneyev, E. Romeo, The pharmacology of neurosteroidogenesis, J. Steroid. Biochem. Mol. Biol. 49 (1994) 385-389.
7. F.E. D'Armour, D.L. Smith, A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther. 72 (1941) 74-79.
8. 3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors, J. Endocrinol. 150 (1996) S33-S42.
9. V.J. DeNoble, K.W. Jones, C.L. Schaeffer, L.M. Bauerle, 3-(±)-2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) and phencyclidine produce a deficit of passive avoidance retention in rats, Eur. J. Pharmacol. 175 (1990) 197-202.
10. L.B. Estall, S.J. Grant, G.A. Cicala, Inhibition of nitric oxide production selectively impairs learning and memory in the rat, Pharmacol. Biochem. Behav. 46 (1993) 959-962.
11. J.F. Flood, E. Roberts, Dehydroepiandrosterone sulfate improves memory in aging mice, Brain Res. 448 (1988) 178-181.
12. J.F. Flood, J.E. Morley, E. Roberts, Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive, Proc. Natl. Acad. Sci. USA 92 (1995) 10806-10810.
13. J.F. Flood, J.E. Morley, E. Roberts, Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it, Proc. Natl. Acad. Sci. USA 89 (1992) 1567-1571.
14. C.A. Frye, The neurosteroid 3α, 5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy, Brain Res. 696 (1995) 113-120.
15. J. Garthwiate, Glutamate, nitric oxide and cell signalling in the nervous system, Trends Neurosci. 14 (1991) 60-67.
16. K.W. Gee, L.D. McCauley, N.C. Lan, A putative receptor for neurosteroids on the GABA-A receptor complex: the pharmacological properties and therapeutic potential of epalons, Crit. Rev. Neurobiol. 9 (1995) 207-227.
17. 3H-dopamine from striatal slices, NeuroReport 3 (1992) 409-412.
18. A.-M. Huang, E.H.Y. Lee, Role of hippocampal nitric oxide in memory retention in rats, Pharmacol. Biochem. Behav. 50 (1995) 327-332.
19. 2+ responses: structure-activity studies, J. Pharmacol. Exp. Ther. 271 (1994) 677-682.
20. J. Itoh, T. Nabeshima, T. Kameyama, Utility of an elevated plus-maze for the evaluation of memory in mice: effect of nootropics, scopolamine and electroconvulsive shock, Psychopharmacology 101 (1990) 27-33.
21. C. Johansson, D.M. Jackson, L. Svensson, Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat, Psychopharmacology 131 (1997) 167-173.
22. S.K. Kulkarni, D.S. Reddy, Neurosteroids: a new class of neuromodulators, Drugs Today 31 (1995) 433-455.
23. G. Lonart, J. Wang, K.M. Johnson, Nitric oxide induces neurotransmitter release from hippocampal slices, Eur. J. Pharmacol. 220 (1992) 271-272.
24. S. Maione, L. Berrino, S. Vitagliano, J. Leyva, F. Rossi, Pregnenolone sulfate increases the convulsant potency of N-methyl-D-aspartate in mice, Eur. J. Pharmacol. 219 (1992) 477-479.
25. M.D. Majewska, Neurosteroids: endogenous bimodal modulators of the GABA-A receptor. Mechanism of action and physiological significance, Prog. Neurobiol. 38 (1992) 379-395.
26. C. Mathis, S.M. Paul, J.N. Crawley, The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task, Psychopharmacology 11 (1994) 201-206.
27. 1 receptors in the mouse forebrain, J. Neurosci. Res. 46 (1996) 734-743.
28. 1-receptors, Behav. Brain. Res. 83 (1997) 159-164.
29. R.L. Melchior, R.F. Ritzmann, Neurosteroids block the memory-impairment effects of ethanol in mice, Pharmacol. Biochem. Behav. 53 (1997) 51-56.
30. N. Miki, Y. Kawabe, K. Kuriyama, Activation of cerebral guanylate cyclase by nitric oxide, Biochem. Biophys. Res. Commun. 75 (1991) 815-856.
31. S. Moncada, R.M.J. Palmer, E.A. Higgs, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev. 43 (1991) 109-142.
32. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus, Proc. Natl. Acad. Sci. USA 92 (1995) 3774-3778.
33. Y. Noda, K. Yamada, T. Nabeshima, Role of nitric oxide in the effect of aging on spatial memory in rats, Behav. Brain Res. 83 (1997) 153-158.
34. M. Ohno, T. Yamamoto, S. Watanabe, Deficits in working memory following inhibition of hippocampal nitric oxide synthesis in the rat, Brain Res. 632 (1993) 36-40.
35. N. Orentretch, J.L. Brind, R.L. Rizer, J.H. Vogelman, Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations through adulthood, J. Clin. Endocrinol. Metab. 59 (1984) 551-555.
36. M.A. Prendergast, J.J. Buccafusco, A.V. Terry Jr., Nitric oxide synthase inhibition impairs spatial navigation learning and induces conditioned taste aversion, Pharmacol. Biochem. Behav. 57 (1997) 347-352.
37. D.S. Reddy, Assessment of nootropic and amnesic activity of centrally acting agents, Ind. J. Pharmacol. 29 (1997) 208-221.
38. D.S. Reddy, S.K. Kulkarni, Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice, Methods Find. Exp. Clin. Pharmacol. 19 (1997) 395-405.
39. D.S. Reddy, S.K. Kulkarni, Chronic neurosteroid treatment prevents development of morphine tolerance and attenuates abstinence behavior in mice, Eur. J. Pharmacol. 337 (1997) 19-25.
40. D.S. Reddy, S.K. Kulkarni, Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice, Brain Res. 752 (1997) 61-71.
41. D.S. Reddy, S.K. Kulkarni, Neuroprotective effects of neurosteroids against hypoxic stress-induced neurotoxicity in naive and FG 7142-treated mice, Ind. J. Pharmacol. 29 (1997) 381-392.
42. D.S. Reddy, S.K. Kulkarni, Potential mechanisms of neurosteroid attenuation of morphine tolerance and dependence, Ind. J. Pharmacol. 30 (1998) 6-15.
43. D.S. Reddy, S.K. Kulkarni, Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice, Methods Find. Exp. Clin. Pharmacol. 19 (1998) (in press).
44. D.S. Reddy, S.K. Kulkarni, The effects of neurosteroids on acquisition and retention of a modified passive avoidance task in mice, Brain Res. (1998) in press.
45. D.S. Reddy, S.K. Kulkarni, Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice, Eur. J. Pharmacol. (1998) in press.
46. D.S. Reddy, S.K. Kulkarni, Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the antistress activity of neurosteroids in mice, Psychopharmacology 128 (1996) 280-292.
47. D.D. Rees, R.M.J. Palmer, R. Schulz, H.F. Hodson, S. Moncada, Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo, Br. J. Pharmacol. 101 (1990) 746-752.
48. E. Roberts, Pregnenolone: from Selye to Alzheimer and a model of the pregnenolone sulfate binding site on the GABA-A receptor, Biochem. Pharmacol. 49 (1995) 1-16.
49. M. Schumacher, P. Robel, E.-E. Baulieu, Development and regeneration of the nervous system: a role for neurosteroids, Dev. Neurosci. 18 (1996) 6-21.
50. F.S. Wu, T.T. Gibbs, D.H. Farb, Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor, Mol. Pharmacol. 40 (1991) 333-336.